Check out this company (RBOT). It is dirt cheap and has interesting technology and products. Oracle's CFO just joined the board yesterday.
Here is the press release:
Thursday November 30, 3:04 pm Eastern Time
Press Release
Oracle's CFO Jeff Henley Joins Computer Motion Board of Directors
New Executive Vice President of Marketing and Sales Is Appointed to Expand Leadership Position in Medical Robotics
SANTA BARBARA, Calif.--(BUSINESS WIRE)--Nov. 30, 2000-- Computer Motion Inc. (Nasdaq:RBOT - news), the pioneer and leader in medical robotics, today announced that Jeffrey O. Henley, executive vice president and chief financial officer of Oracle Corp. (Nasdaq:ORCL - news), has joined its board of directors.
The company also announced that William Meloche has been appointed as executive vice president of Marketing and Sales.
Henley has managed Oracle's finance and administration organization since 1991. He is also responsible for Oracle's Legal, Human Resources and Manufacturing and Distribution organizations. During his tenure, Oracle's business has grown from under $1 billion to more than $10 billion in annual revenue. He is a member of the board of directors at Oracle and is a member of the Financial Executives Institute.
``As Computer Motion moves forward, it is important to strengthen our management and board of directors to support high growth with solid financial control,'' stated Robert W. Duggan, chairman and chief executive officer of Computer Motion.
``Jeff brings terrific management experience having been a significant part of several large, fast-growing, global technology businesses. His e-commerce and database experience will be invaluable to the company as we become much larger as a result of rapid mainstream adoption of the technology that we have pioneered over the past 11 years to deliver improved patient outcomes and reduced health-care costs.
``As we continue to become a larger commercial enterprise, his finance guidance and counsel will be very important in managing our expenses, investing, and driving the profitability of our business,'' Duggan added.
Meloche will implement an integrated marketing and sales strategy to expand the company's business. He was formerly president and CEO of Meloche Communications International, a communications agency focused on strategic marketing to global markets. Previous clients include American Express, Air Canada, Timex and Toyota Corp. He is a respected communications innovator and the architect of the Customer Care Process, as practiced by several leading service corporations.
``He knows what it takes to build a profitable business by differentiating a company's products and services and by creating demand,'' added Duggan.
Computer Motion is a high-tech medical device company evolving surgical practices to enhance patient lives. The company develops, manufactures and markets proprietary computer-enhanced and robotic surgical systems, which enhance surgeons' capabilities, improve outcomes and reduce costs.
Computer Motion's products include the voice-controlled AESOP® endoscope positioning system; the HERMES(TM) Control Center, a centralized system which enables the surgeon to voice control a network of ``smart'' medical devices; and the ZEUS(TM) Robotic Surgical System for new minimally invasive microsurgery procedures, such as endoscopic, beating heart bypass surgery. The ZEUS System is CE-Marked for commercial sale in the European Community and is co-marketed by Computer Motion and Medtronic (NYSE: MDT - news).
Computer Motion has completed an FDA-approved Phase 1 Investigational Device Exemption (IDE) coronary bypass study and has initiated an IDE mitral valve surgery and general laparoscopic studies with the ZEUS System. Also, the company has begun the second phase of its tubal reanastomosis study. The company's Web site is www.ComputerMotion.com.
This press release contains forward-looking statements concerning the company's business and products. Actual results may differ materially depending on a number of risk factors, including the risks of competition and competing technologies, duration or suspension of clinical studies, regulatory clearances and approvals, and physician, hospital and payor acceptance of the company's products. These factors and other risks inherent in the company's business are described from time to time in the company's Securities and Exchange Commission filings, including its Annual Report on Form 10-K. The company undertakes no obligation to revise the forward-looking statements contained herein to reflect events or circumstances after the date hereof to reflect the occurrence of unanticipated events.
--------------------------------------------------------------------------------
Contact:
Computer Motion Inc., Santa Barbara
Gordon L. Rogers, 805/968-9600, ext. 155
Holley Malia, 805/968-9600, ext. 179 |
